Respirology

NACI recommended that seniors who are 80 years and older, residents of long-term care homes, and adults and children six months and older who are moderately to severely immunocompromised should get two doses of COVID-19 vaccine per year.

Study compares twice-daily budesonide–glycopyrronium–formoterol (Breztri) metered-dose inhaler to daily fluticasone–umeclidinium–vilanterol (Trelegy) dry powder inhaler. 

New study on anaphylaxis in adults reveals what allergens prompt certain symptoms.

U.S. study examines effectiveness of respiratory syncytial virus (RSV) vaccine in reducing inpatient and emergency room visits due to RSV-related lower respiratory tract disease.

Taping your mouth closed in an effort to stop snoring is all the rage on social media.

Pediatric asthma is a prevalent chronic respiratory condition, affecting more than 850,000 children in Canada under age 14.

A new study from Korea may pose more questions than it answers.

The injectable monoclonal antibody prevents respiratory syncytial virus in newborns and infants during their first RSV season and at-risk children during their second RSV season.